Blue Jet Healthcare share price

High risk
  • 56%Low risk
  • 56%Moderate risk
  • 56%Balanced risk
  • 56%High risk
  • 56%Extreme risk
  • 875.00(2.16%)
    June 20, 2025 15:29:52 PM IST
    • NSE
    • BSE
  • Vol : 197.16K (NSE + BSE)
    Last 20 day avg : 435.38 K

Blue Jet Healthcare is trading 2.16% upper at Rs 875.00 as compared to its last closing price. Blue Jet Healthcare has been trading in the price range of 875.00 & 845.05. Blue Jet Healthcare has given 53.23% in this year & -9.27% in the last 5 days. Blue Jet Healthcare has TTM P/E ratio 50.28 as compared to the sector P/E of 22.38.There are 6 analysts who have initiated coverage on Blue Jet Healthcare. There are 2 analysts who have given it a strong buy rating & 2 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 110.10 Crores in its last quarter.Listed peers of Blue Jet Healthcare include R R Kabel (-0.62%), Acme Solar Holdings (0.22%), Blue Jet Healthcare (2.16%).The Mutual Fund holding in Blue Jet Healthcare was at 0.62% in 31 Mar 2025. The MF holding has decreased from the last quarter. The FII holding in Blue Jet Healthcare was at 2.28% in 31 Mar 2025. The FII holding has increased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Key Metrics

Updated on Jun 21, 2025, 12:07 PM UTC

  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.14
    Lower than industry
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    13.25
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    49.16
    Higher than historical values
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.02
    Higher than industry
  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    -
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    -
Price range
Day Range
Lowest
845.05
Highest
875.00
52 week range
Lowest
386.50
Highest
985.60
Blue Jet Healthcare Financials
Financials
Financials include key reports like the Profit & Loss Statement (P&L), Balance Sheet, and Cash Flow Statement, providing insights into a company's performance, financial health, and liquidity
View all
  • Income
  • Balance Sheet
  • Cash Flow
Loading...
Units in the chart are in crores
Insights
  • Financial
  • Valuation
    • financial-insightsCompany is profitable
    • financial-insightsThe company has grown its March quarter profit by 177.67% from Rs 39.65 crore to Rs 110.10 crore, year-on-year
    • financial-insightsThe debt to equity of the company is higher than the industry median
    • financial-insightsCompany can comfortably pay off its interest obligations with its earnings
Blue Jet Healthcare Technical Analysis
Pivot Level - classic
Info
Key price levels (support and resistance) calculated using the previous day's high, low, and close, aiding in technical analysis and trading decisions
  • R1
  • 978.28
  • R2
  • 1,052.22
  • R3
  • 1,118.83
Pivot911.67
  • S1
  • 837.73
  • S2
  • 771.12
  • S3
  • 697.18
Short Term
Info
Considers price movement over the last 1-2 weeks
Not Available
Long Term
Info
Considers price movement over the last 6 months
Not Available
  • Very Bearish
  • Bearish
  • Neutral
  • Very Bullish
  • Bullish
Trends unavailable at the moment.
Blue Jet Healthcare Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
R R Kabel
Neutral
1,317.65-0.6214,909.1748.016.950.532.64
Acme Solar Holdings
Neutral
246.850.2215,015.8551.103.30.08229.73
Blue Jet Healthcare
Neutral
875.002.1615,248.5448.6713.110.121.46
Niva Bupa Health Insurance
Neutral
81.291.5914,681.9266.703.87-6.62
Doms Industries
Neutral
2,450.702.0514,831.9572.1314.540.1014.83
Blue Jet Healthcare Shareholding
View All
Shareholding Pattern
Breakdown of a company's ownership structure, showing stakes held by Promoters, Mutual Funds, FII(s) & Others.
    No Data
    Shareholding pattern for Blue Jet Healthcare is currently unavailable
    Please check back later.
    Shareholding Insights
    • InsightsPromoter(s) holds a high stake in the company at 86.00%
    • InsightsFIIs are invested in this company
    • InsightsFIIs holding has increased by 1.18 percentage points from previous quarter
    • InsightsMutual Funds holding has decreased by 0.57 percentage points from previous quarter
    Mutual Fund Ownership
    View all
    Samco Special Opportunities Fund Regular Growth
    NA
    • Amount Invested (Cr.) 3.95
    • % of AUM 2.44
    TrustMF Small Cap Fund Regular Growth
    NA
    • Amount Invested (Cr.) 18.44
    • % of AUM 1.90
    UTI Small Cap Fund Regular Growth
    2/5
    • Amount Invested (Cr.) 45.80
    • % of AUM 1.01
    WhiteOak Capital Pharma and Healthcare Fund Regular Growth
    NA
    • Amount Invested (Cr.) 1.88
    • % of AUM 0.56
    Samco Multi Cap Fund Regular Growth
    NA
    • Amount Invested (Cr.) 1.17
    • % of AUM 0.32
    Blue Jet Healthcare Corporate Actions
    View all
    • Board Meetings
    • AGM
    • Dividends
    • Bonus
    • Split
    • Rights
    Meeting DatePurpose
    2025-05-14Audited Results, Final Dividend & Others
    2025-01-29Quarterly Results
    2024-10-29Quarterly Results
    2024-08-06Quarterly Results
    2024-05-25Audited Results & Dividend
    About the company Blue Jet Healthcare
    • Industry
    • ISININE0KBH01020
    • BSE Code544009
    • NSE CodeBLUEJET
    Blue Jet Healthcare Limited is an India-based company, specializing in manufacturing integrated contrast media, artificial sweeteners and its salts, as well as niche pharmaceutical intermediaries and active pharmaceutical ingredients (APIs). The Company serves as a business-to-business (B2B) company. Its integrated contrast media intermediate product categories include x-ray contrast media intermediates and MRI contrast media intermediates. Its x-ray contrast media intermediates include non-ionic APIs and ionic APIs. It manufactures saccharin and supplies to healthcare, pharma, animal feed, food and beverages industries globally. The Company's offerings include insoluble saccharin, saccharin sodium and insoluble saccharin. Its advance pharmaceutical intermediates and API products include Vanillic Acid, Docusate Sodium and TosMIC. It offers end-to-end integrated solutions from process development to commercialization of NCEs, advance intermediates, APIs and building blocks.
    • Management Info
    • Akshay AroraExecutive Chairman of the Board
    • Ganesh KaruppannanChief Financial Officer
    • Vimalendu SinghChief Operating Officer
    • Sweta PoddarCompliance Officer, Company Secretary
    • Shiven AroraManaging Director, Executive Director
    • Popat KedarExecutive Whole-Time Director
    • Naresh ShahExecutive Director
    Blue Jet Healthcare Share Price FAQs

    Blue Jet Healthcare is trading at 875.00 as on Fri Jun 20 2025 09:59:52. This is 2.16% upper as compared to its previous closing price of 856.50.

    The market capitalization of Blue Jet Healthcare is 15248.54 Cr as on Fri Jun 20 2025 09:59:52.

    The average broker rating on Blue Jet Healthcare is Buy. The breakup of analyst rating is given below -

    • 2 analysts have given a strong buy rating
    • 2 analysts have given a buy rating
    • 2 analysts have given a hold rating
    • 0.00 analysts have given a sell rating
    • 0.00 analysts have given a strong sell rating

    The 52 wk high for Blue Jet Healthcare is 985.60 whereas the 52 wk low is 386.50

    Blue Jet Healthcare can be analyzed on the following key metrics -

    • TTM P/E: 50.28
    • Sector P/E: 22.38
    • Dividend Yield: 0.14%
    • D/E ratio: 0.02

    Blue Jet Healthcare reported a net profit of 305.20 Cr in 2025.

    The Mutual Fund Shareholding was 0.62% at the end of 31 Mar 2025.